title: Development of a framework for enhancing the transparency, reproducibility and communication of the benefit-risk balance of medicines.
authors.affiliation: Risk Management and Epidemiology, Purdue Pharma LP, Stamford, Connecticut, USA. paul.coplan@pharma.com
authors.forename: P M
authors.initials: PM
authors.lastname: Coplan
authors.forename: R A
authors.initials: RA
authors.lastname: Noel
authors.forename: B S
authors.initials: BS
authors.lastname: Levitan
authors.forename: J
authors.initials: J
authors.lastname: Ferguson
authors.forename: F
authors.initials: F
authors.lastname: Mussen
mesh_terms: D003142:Communication; D003657:Decision Making; D004345:Drug Industry; D064420:Drug-Related Side Effects and Adverse Reactions; D011358:Product Surveillance, Postmarketing; D015203:Reproducibility of Results; D018570:Risk Assessment; D013223:Statistics as Topic